Dr. Alexander Kuo, MD

Dr. Kuo practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Kuo's NPI, 1912032764, was assigned on February 22, 2007. Dr. Kuo graduated from UCSF School of Medicine in 2001. Dr. Kuo's California license number on file is A86787.

Dr. Kuo's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Kuo's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Kuo to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuo practices, 3 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Kuo's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Kuo is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Kuo's licenses on file in 2 states: California and Washington.

CMS data shows 504 Medicare services from Dr. Kuo across 10 procedure codes in 2024, for 342 Medicare patients. Medicare paid $43,412 for them.

CMS counts 342 Medicare patients who saw Dr. Kuo in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kuo's median patient age at 66, with 46% women.

In 2024, Dr. Kuo wrote 690 Medicare Part D claims for 123 patients. 67% of them were for generic drugs. CMS names the drug for 585 of them, across 11 drugs with 11 or more claims each, at $423,534 in total drug cost. In 2023, CMS named 811 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Kuo for performance year 2024, reported as part of a group. Dr. Kuo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kuo as offering telehealth.

Dmand AI links 37 papers to Dr. Kuo, published from 2011 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Antiviral Agents. Dr. Kuo has published most often in ACG Case Rep J. Dr. Kuo's most frequent co-authors are Walid S. Ayoub, MD, Ju Dong Yang, MD and Hirsh Divyang Trivedi, MD.

Dmand AI links Dr. Kuo to 5 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Acute-On-Chronic Liver Failure, Hepatitis and Hepatitis, Alcoholic. Vital Therapies, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Kuo that name 1 trial.

CMS Open Payments shows 77 general payments to Dr. Kuo from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Gilead Sciences, Inc. paid the most, $34,800. It also lists 2 research payments totaling $1,741 in 2019, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Kuo, most recently Top Doctors in 2018.

Dr. Kuo graduated from UCSF School of Medicine in 2001. Dr. Kuo is a member of American Association for the Study of Liver Diseases, American Society of Transplantation and European Association for the Study of the Liver.

Dr. Kuo is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.